(Q42836936)

English

Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia

scientific article published on September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1 reference

based on heuristic

inferred from title

author name string

Rudolf Weide

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Ulrike Mergenthaler

2

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Vera Friesenhahn

3

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Kristina Kleboth

4

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Jochen Heymanns

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Jörg Thomalla

6

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Hubert Köppler

7

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1468-1474

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Antibody therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Bendamustine mitoxantrone and rituximab (BMR): a new effective regimen for refractory or relapsed indolent lymphomas

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response

1 reference

https://api.crossref.org/works/10.1080%2F10428190903166330

21 January 2018

Identifiers

10.1080/10428190903166330

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42836936&oldid=2172417388"